Evidence-based toxicology for the 21st century: opportunities and challenges.
暂无分享,去创建一个
Sebastian Hoffmann | Richard A Becker | Thomas Hartung | Michael Holsapple | Ted Simon | Grace Patlewicz | Kim Boekelheide | Rashid Shaikh | Richard Judson | Abigail Jacobs | Ed Carney | Joanne Zurlo | Robert Chapin | R. Judson | G. Patlewicz | T. Hartung | M. Andersen | K. Boekelheide | M. Stephens | R. Scherer | S. Fitzpatrick | J. Fowle | K. Betts | S. Hoffmann | R. Becker | R. Chapin | T. Simon | T. Pastoor | A. Jacobs | O. Naidenko | Patricia Harlow | Martin L Stephens | Melvin Andersen | Kellyn Betts | Dennis Devlin | Suzanne Fitzpatrick | John R Fowle | Olga Naidenko | Tim Pastoor | Andrew Rowan | Roberta Scherer | Douglas Wolf | M. Holsapple | P. Harlow | J. Zurlo | A. Rowan | D. Wolf | Rashid Shaikh | E. Carney | D. Devlin
[1] Krishna Prasad,et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium , 2010, Nature Biotechnology.
[2] James A. Swenberg,et al. Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[3] Philip Hewitt,et al. Performance of novel kidney biomarkers in preclinical toxicity studies. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[4] Seema K. Schappelle,et al. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[5] Nancy G. Doerrer,et al. Identification and Characterization of Adverse Effects in 21 st Century Toxicology , 2012 .
[6] Patrice Sutton,et al. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. , 2011, Health affairs.
[7] Eliseo Guallar,et al. Arsenic Exposure and Hypertension: A Systematic Review , 2011, Environmental health perspectives.
[8] A. Oxman,et al. The origins, evolution, and future of The Cochrane Database of Systematic Reviews , 2009, International Journal of Technology Assessment in Health Care.
[9] Sebastian Hoffmann,et al. Diagnosis: toxic!--trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[10] Amy G. Aslamkhan,et al. Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury , 2010, Nature Biotechnology.
[11] G. Christiaens,et al. Leading change , 2018, Leadership Transitions in Universities.
[12] M. Longnecker,et al. Evaluation of the Association between Arsenic and Diabetes: A National Toxicology Program Workshop Review , 2012, Environmental health perspectives.
[13] T. Skopek,et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function , 2010, Nature Biotechnology.
[14] T. Woodruff,et al. Conrad and Becker’s “10 Criteria” Fall Short of Addressing Conflicts of Interest in Chemical Safety Studies , 2011, Environmental health perspectives.
[15] Serafino Pantano,et al. Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury , 2010, Nature Biotechnology.
[16] E. Guallar,et al. Lead Exposure and Cardiovascular Disease—A Systematic Review , 2006, Environmental health perspectives.
[17] T Hartung,et al. Toward an evidence-based toxicology , 2006, Human & experimental toxicology.
[18] I. Zineh,et al. Qualifying biomarkers for use in drug development: a US Food and Drug Administration overview. , 2011, Expert opinion on medical diagnostics.
[19] T. Hartung. Evidence-based toxicology - the toolbox of validation for the 21st century? , 2010, ALTEX.
[20] S. Covey. The seven habits of highly effective people : restoring the character ethic , 1989 .
[21] Joanne Zurlo. Evidence-based Toxicology Collaboration Kick-off Meeting , 2011 .
[22] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[23] A. Detsky,et al. Evidence-based medicine. A new approach to teaching the practice of medicine. , 1992, JAMA.
[24] Thomas Hartung. Food for thought... on evidence-based toxicology. , 2009, ALTEX.
[25] Ellen Silbergeld,et al. Evidence-based toxicology: strait is the gate, but the road is worth taking. , 2013, ALTEX.
[26] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[27] Syril Pettit,et al. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[28] Melvin E. Andersen,et al. Toxicity Testing in the 21st Century: Defining New Risk Assessment Approaches Based on Perturbation of Intracellular Toxicity Pathways , 2011, PloS one.
[29] M. Hamburg,et al. Advancing Regulatory Science , 2011, Science.
[30] Kevork Hopayian,et al. Essential Evidence-based Medicine , 2005, ACP Journal Club.
[31] Michael S Victoroff,et al. Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.
[32] Thomas Hartung,et al. Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. , 2013, ALTEX.
[33] R. Becker,et al. Enhancing Credibility of Chemical Safety Studies: Emerging Consensus on Key Assessment Criteria , 2010, Environmental health perspectives.